Ayujoy Herbals Ltd. and Anthea, Inc. Announce Product Sourcing and Marketing Collaboration

3 years ago

Ayujoy Herbals Ltd. and Anthea, Inc. Announce Product Sourcing and Marketing Collaboration MAG Mountain WaterBerlin, Germany, May 31, 2022 (GLOBE…

PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe

3 years ago

Promising preliminary clinical results validate expansion of study initially into the United KingdomFLORHAM PARK, N.J., May 31, 2022 (GLOBE NEWSWIRE)…

Compass Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference

3 years ago

BOSTON, May 31, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics…

Cullinan Oncology to Present Updated Data Demonstrating the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting

3 years ago

Updated data from Phase 1/2a study show median duration of response greater than 21 months and median progression-free survival of…

Scientific Leaders Agree on Promise of Enochian BioSciences

3 years ago

LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences is working to solve our greatest public…

Sight Sciences’ OMNI® Surgical System Reduces IOP, Daily Fluctuations in IOP and Medication Use, as Shown in Newly Published 12-Month Clinical Data

3 years ago

Suppression of diurnal, or daily, fluctuations in IOP, is a significant and independent risk factor for the progression of glaucomaThese…

Enlivex Announces New Preclinical Data in Ovarian Cancer Showing a Substantial Survival Benefit when Allocetra is Combined with PD-1 Checkpoint Inhibition at the American Society of Clinical Oncology (ASCO) Annual Meeting

3 years ago

Ovarian Cancer ID8 Study – Survival Probability Source imageStand-alone therapy with PD1 checkpoint inhibitors has shown limited efficacy against ovarian…

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

3 years ago

LAKEWOOD, Colo., May 31, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q22”)…

Axsome Therapeutics Announces Publication of Pivotal GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder in The Journal of Clinical Psychiatry

3 years ago

AXS-05 (dextromethorphan-bupropion) demonstrated rapid, substantial, and statistically significant antidepressant efficacy compared to placebo starting 1 week after treatmentNEW YORK, May…

Theratechnologies Announces New Head of Investor Relations

3 years ago

MONTREAL, May 31, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or “the Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company…